Scarica l'app Stockscreener
187.22
1.28%
-2.42
Dopo l'orario di chiusura:
187.22
Precedente Chiudi:
$189.64
Aprire:
$187.69
Volume 24 ore:
1.90M
Relative Volume:
1.84
Capitalizzazione di mercato:
$15.46B
Reddito:
$8.31B
Utile/perdita netta:
$747.89M
Rapporto P/E:
30.20
EPS:
6.2
Flusso di cassa netto:
$1.23B
1 W Prestazione:
-11.76%
1M Prestazione:
-37.12%
6M Prestazione:
-40.51%
1 anno Prestazione:
-30.65%
Intervallo 1D:
$183.38
$189.85
Intervallo di 1 settimana:
$183.38
$215.60
Portata 52W:
$183.38
$347.72
Icon Plc Stock (ICLR) Company Profile
Nome
Icon Plc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ICLR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ICLR | 187.22 | 15.46B | 8.31B | 747.89M | 1.23B | 6.20 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-15 | Iniziato | Truist | Buy |
| 2023-09-13 | Iniziato | TD Cowen | Outperform |
| 2023-01-17 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-09-07 | Iniziato | UBS | Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-14 | Iniziato | Citigroup | Neutral |
| 2021-04-13 | Ripresa | BofA Securities | Neutral |
| 2021-04-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Iniziato | Barclays | Equal Weight |
| 2021-03-01 | Aggiornamento | UBS | Neutral → Buy |
| 2021-02-26 | Aggiornamento | Truist | Hold → Buy |
| 2020-07-24 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Iniziato | Deutsche Bank | Hold |
| 2020-01-27 | Downgrade | SunTrust | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-09-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-25 | Aggiornamento | Mizuho | Neutral → Buy |
| 2018-10-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Iniziato | UBS | Sell |
| 2018-04-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Reiterato | Mizuho | Neutral |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
| 2017-10-27 | Reiterato | Barclays | Equal Weight |
| 2017-09-11 | Iniziato | BofA/Merrill | Buy |
| 2017-07-31 | Aggiornamento | SunTrust | Hold → Buy |
| 2017-07-27 | Reiterato | Mizuho | Neutral |
| 2017-06-29 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Icon Plc Borsa (ICLR) Ultime notizie
Prudential expands preferred healthcare network in partnership with Icon Cancer Centre - Media OutReach
ICON Plc stock hits 52-week low at $208.38 amid market shifts - Investing.com India
ICON to Present at London Healthcare Conference - TipRanks
ICON plc to Present at the Jefferies London Healthcare Conference - Business Wire
RNA Therapy Clinical Trials Market Size, Scope and Growth to 2031 - InsightAce Analytic
Rose Kidd, ICON – Winner of WMB Businesswoman Award 2024 - Women Mean Business
Icon PLC (ICLR) Shares Up 3.48% on Nov 6 - GuruFocus.com
Life Sciences BPO Market Set to Witness Significant Growth by 2024-2031:Catalent, Inc., Covance, Inc., Fareva, - EIN News
Icon (FRA:IJF) GF Value Rank : 10 (As of Nov. 04, 2024) - GuruFocus.com
ICON Plc stock touches 52-week low at $219.87 amid market shifts - Investing.com Australia
Icon PLC (ICLR) Trading 3.72% Higher on Oct 2 - GuruFocus.com
ICLR Misses on Q3 Earnings, Lowers 2024 Guidance, Stock Falls - Yahoo Finance
ICON's $650 Million Power Play: Can This Bold Move Reverse a 21% Stock Plunge? - Yahoo Finance UK
Baird Downgrades ICON Public Limited (ICLR) - MSN
Icon plc Strengthens Investor Confidence with Secured Notes - TipRanks
Earnings call: ICON PLC faces headwinds, eyes strategic growth By Investing.com - Investing.com Australia
Earnings call: ICON PLC faces headwinds, eyes strategic growth - Investing.com India
Icon Earnings: Shares Tank as Elevated Cancellations Reduce 2024 Guidance - Morningstar
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Pharmaceutical Contract Sales Outsourcing (CSO) Market Projected To Witness Substantial Growth, 2024-2031: - EIN News
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Cha - GuruFocus.com
ICON Plc stock touches 52-week low at $227.56 amid market shifts - Investing.com Australia
U.S. Markets Finished Mixed Thursday As Tesla Led, Icon PLC Lagged - Barron's
ICON stock slips after guidance cut (ICLR:NASDAQ) - Seeking Alpha
Icon PLC Down Over 19%, on Pace for Largest Percent Decrease Since March 1999 — Data Talk - Morningstar
ICON Plc stock touches 52-week low at $227.56 amid market shifts By Investing.com - Investing.com South Africa
Icon shares maintain Outperform rating with Leerink despite market pressures - Investing.com
Baird downgrades ICON plc stock, slashes outlook on lower earnings and revenue guidance - Investing.com
S&P 500 Futures Up in Premarket Trading; Icon PLC, Darling Ingredients Lag - Barron's
ICON revenue slumps 1.2% to USD 2,030M in Q3 2024 - Medical Buyer
Icon PLC: Q3 Earnings Snapshot - Houston Chronicle
Icon PLC (ICLR) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
ICON Reports Third Quarter 2024 Results - sharewise
ICON Reports Mixed Q3 Results, Secures Key Partnership - TipRanks
Icon PLC: Q3 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria
ICON plc shares tumble as Q3 results miss estimates, guidance cut - Investing.com Australia
ICON plc shares tumble as Q3 results miss estimates, guidance cut By Investing.com - Investing.com South Africa
Imaging CRO Market Is Booming Worldwide 2025-2030 | WORLDCARE - openPR
Icon PLC (ICLR) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Randomization and Trial Supply Management Market 2024-2031- Calyx, Almac, ICON plc, Trialogics, IBM, Medpace CRO, Endpoi – IndiaPolitics.com - IndiaPolitics.com
Redburn Atlantic Initiates Coverage of ICON Public Limited (ICLR) with Neutral Recommendation - Nasdaq
ICON plc stock faces Neutral rating as analyst flags downside risk to growth projections - Investing.com Australia
Biomarker Research Services Market Synopsis: Trends, Industry Insights, and Growth Forecast 2024-2031 |BioIVT, - EIN News
Onco-hematology Molecular Testing Market Size to Reach USD 1.5 billion by 2031 with a 12.5% CAGR, Boosted by Next-Generation Blood Cancer Diagnostics| Exclusive Report by Transparency Market Research, Inc. - GlobeNewswire Inc.
Icon Plc Azioni (ICLR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.04%
3.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):